Some of Britain’s top model agencies colluded to fix prices charged to retailers, fashion brands and other customers, the competition regulator has alleged. FM Models, Models 1, Premier, Storm and Viva agreed to exchange competitively sensitive information, including future prices, from April 2013 to March 2015, the Competition and Markets Authority alleged. In some cases, agencies agreed a common approach to pricing, the CMA added.
The allegations affect agencies at the pinnacle of the British modelling industry. Premier was the agency that launched Naomi Campbell’s career, Storm discovered Kate Moss and Cara Delevingne. Models 1 have represented Sophie Dahl and Yasmin Le Bon while Viva’s models include Stella Tennant and Natalia Vodianova.
The agencies allegedly used the Association of Model Agents trade association as a vehicle for price coordination when their representatives controlled the AMA’s managing council. The association circulated regular “AMA alerts” encouraging agencies to reject fees offered by customers and negotiate higher payments, the CMA said.
The CMA published its provisional findings after an investigation that began in March 2015. The regulator carried out dawn raids on agencies’ offices, interviewed staff and seized computer hard drives and files last year in operations that stunned the industry.
Full Content: The Guardian
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas